Targeting PI3K/AKT Pathway is an Effective Strategy for the Treatment of Neuroendocrine Tumors Harboring PIK3CA Mutations
Year: 2011
Type: article
Source: Gastroenterology
Authors: Jun Song, Jing Li, Ji Tae Kim, Heidi Weiss, Courtney M. Townsend, B.M. Evers
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1894435717
